28274957 |
An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer
Hanker, AB,
Brewer, MR,
Sheehan, JH,
Koch, JP,
Sliwoski, GR,
Nagy, R,
Lanman, R,
Berger, MF,
Hyman, DM,
Solit, DB,
He, J,
Miller, V,
Cutler, RE,
Lalani, AS,
Cross, D,
Lovly, CM,
Meiler, J,
Arteaga, CL
|
Cancer Discov |
2017 |
18413839 |
EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation
Trowe, T,
Boukouvala, S,
Calkins, K,
Cutler, RE,
Fong, R,
Funke, R,
Gendreau, SB,
Kim, YD,
Miller, N,
Woolfrey, JR,
Vysotskaia, V,
Yang, JP,
Gerritsen, ME,
Matthews, DJ,
Lamb, P,
Heuer, TS
|
Clin. Cancer Res. |
2008 |